Snakebite Envenoming: WHO Launches First-Ever Strategy For Prevention & Control 24/05/2019 Catherine Saez The World Health Organization today launched its first-ever global strategy for the prevention and control of snakebite envenoming, just one year after the World Health Assembly agreed on a resolution to fight this neglected cause of death and disability.Continue reading -> Image Credits: Catherine Saez. Following 110 years of neglect, an official day for Chagas disease is declared 24/05/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 24 May 2019 The delegates at the World Health Assembly (WHA) have today approved the creation of a World Chagas Day. People affected by Chagas worldwide celebrate this important step in fighting for recognition of this neglected disease.Continue reading -> Image Credits: DNDi. Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets.Continue reading -> Image Credits: Max Pixel, Catherine Saez. Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member at the Graduate Institute of Geneva and Harvard T.H. Chan School of Public Health and researcher into medicines access policies, examines the evidence behind the debate over whether greater transparency can really help reduce prices.Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May).Continue reading -> Image Credits: UnternehmerTUM/@birdyfoto.de. US Faces Off Against 43 Countries On Sexual & Reproductive Health & Rights 24/05/2019 David Branigan The United States faced off against 43 other countries at the 72nd World Health Assembly this week regarding a proposal to include language protecting sexual and reproductive health and rights (SRHR) in the draft political declaration on universal health coverage (UHC), due to be issued at a UN high-level meeting in September. Continue reading -> Image Credits: WHO. Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise text.Continue reading -> Image Credits: Pxhere. Green Light For First-Ever WHO Strategy On Health, Environment And Climate Change 23/05/2019 Catherine Saez Faced by an annual death toll of nearly 13 million people due to environmental risks, the World Health Assembly today approved a first-ever global strategy that sets out a transformative plan for action on Health, environment and climate change.Continue reading -> Image Credits: WHO. Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year.Continue reading -> Image Credits: WHO, Vital Strategies. How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- and gene-therapies and diagnostic tests.Continue reading -> Image Credits: Dashiell Love. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Following 110 years of neglect, an official day for Chagas disease is declared 24/05/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 24 May 2019 The delegates at the World Health Assembly (WHA) have today approved the creation of a World Chagas Day. People affected by Chagas worldwide celebrate this important step in fighting for recognition of this neglected disease.Continue reading -> Image Credits: DNDi. Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets.Continue reading -> Image Credits: Max Pixel, Catherine Saez. Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member at the Graduate Institute of Geneva and Harvard T.H. Chan School of Public Health and researcher into medicines access policies, examines the evidence behind the debate over whether greater transparency can really help reduce prices.Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May).Continue reading -> Image Credits: UnternehmerTUM/@birdyfoto.de. US Faces Off Against 43 Countries On Sexual & Reproductive Health & Rights 24/05/2019 David Branigan The United States faced off against 43 other countries at the 72nd World Health Assembly this week regarding a proposal to include language protecting sexual and reproductive health and rights (SRHR) in the draft political declaration on universal health coverage (UHC), due to be issued at a UN high-level meeting in September. Continue reading -> Image Credits: WHO. Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise text.Continue reading -> Image Credits: Pxhere. Green Light For First-Ever WHO Strategy On Health, Environment And Climate Change 23/05/2019 Catherine Saez Faced by an annual death toll of nearly 13 million people due to environmental risks, the World Health Assembly today approved a first-ever global strategy that sets out a transformative plan for action on Health, environment and climate change.Continue reading -> Image Credits: WHO. Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year.Continue reading -> Image Credits: WHO, Vital Strategies. How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- and gene-therapies and diagnostic tests.Continue reading -> Image Credits: Dashiell Love. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets.Continue reading -> Image Credits: Max Pixel, Catherine Saez. Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member at the Graduate Institute of Geneva and Harvard T.H. Chan School of Public Health and researcher into medicines access policies, examines the evidence behind the debate over whether greater transparency can really help reduce prices.Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May).Continue reading -> Image Credits: UnternehmerTUM/@birdyfoto.de. US Faces Off Against 43 Countries On Sexual & Reproductive Health & Rights 24/05/2019 David Branigan The United States faced off against 43 other countries at the 72nd World Health Assembly this week regarding a proposal to include language protecting sexual and reproductive health and rights (SRHR) in the draft political declaration on universal health coverage (UHC), due to be issued at a UN high-level meeting in September. Continue reading -> Image Credits: WHO. Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise text.Continue reading -> Image Credits: Pxhere. Green Light For First-Ever WHO Strategy On Health, Environment And Climate Change 23/05/2019 Catherine Saez Faced by an annual death toll of nearly 13 million people due to environmental risks, the World Health Assembly today approved a first-ever global strategy that sets out a transformative plan for action on Health, environment and climate change.Continue reading -> Image Credits: WHO. Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year.Continue reading -> Image Credits: WHO, Vital Strategies. How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- and gene-therapies and diagnostic tests.Continue reading -> Image Credits: Dashiell Love. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member at the Graduate Institute of Geneva and Harvard T.H. Chan School of Public Health and researcher into medicines access policies, examines the evidence behind the debate over whether greater transparency can really help reduce prices.Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May).Continue reading -> Image Credits: UnternehmerTUM/@birdyfoto.de. US Faces Off Against 43 Countries On Sexual & Reproductive Health & Rights 24/05/2019 David Branigan The United States faced off against 43 other countries at the 72nd World Health Assembly this week regarding a proposal to include language protecting sexual and reproductive health and rights (SRHR) in the draft political declaration on universal health coverage (UHC), due to be issued at a UN high-level meeting in September. Continue reading -> Image Credits: WHO. Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise text.Continue reading -> Image Credits: Pxhere. Green Light For First-Ever WHO Strategy On Health, Environment And Climate Change 23/05/2019 Catherine Saez Faced by an annual death toll of nearly 13 million people due to environmental risks, the World Health Assembly today approved a first-ever global strategy that sets out a transformative plan for action on Health, environment and climate change.Continue reading -> Image Credits: WHO. Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year.Continue reading -> Image Credits: WHO, Vital Strategies. How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- and gene-therapies and diagnostic tests.Continue reading -> Image Credits: Dashiell Love. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May).Continue reading -> Image Credits: UnternehmerTUM/@birdyfoto.de. US Faces Off Against 43 Countries On Sexual & Reproductive Health & Rights 24/05/2019 David Branigan The United States faced off against 43 other countries at the 72nd World Health Assembly this week regarding a proposal to include language protecting sexual and reproductive health and rights (SRHR) in the draft political declaration on universal health coverage (UHC), due to be issued at a UN high-level meeting in September. Continue reading -> Image Credits: WHO. Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise text.Continue reading -> Image Credits: Pxhere. Green Light For First-Ever WHO Strategy On Health, Environment And Climate Change 23/05/2019 Catherine Saez Faced by an annual death toll of nearly 13 million people due to environmental risks, the World Health Assembly today approved a first-ever global strategy that sets out a transformative plan for action on Health, environment and climate change.Continue reading -> Image Credits: WHO. Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year.Continue reading -> Image Credits: WHO, Vital Strategies. How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- and gene-therapies and diagnostic tests.Continue reading -> Image Credits: Dashiell Love. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US Faces Off Against 43 Countries On Sexual & Reproductive Health & Rights 24/05/2019 David Branigan The United States faced off against 43 other countries at the 72nd World Health Assembly this week regarding a proposal to include language protecting sexual and reproductive health and rights (SRHR) in the draft political declaration on universal health coverage (UHC), due to be issued at a UN high-level meeting in September. Continue reading -> Image Credits: WHO. Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise text.Continue reading -> Image Credits: Pxhere. Green Light For First-Ever WHO Strategy On Health, Environment And Climate Change 23/05/2019 Catherine Saez Faced by an annual death toll of nearly 13 million people due to environmental risks, the World Health Assembly today approved a first-ever global strategy that sets out a transformative plan for action on Health, environment and climate change.Continue reading -> Image Credits: WHO. Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year.Continue reading -> Image Credits: WHO, Vital Strategies. How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- and gene-therapies and diagnostic tests.Continue reading -> Image Credits: Dashiell Love. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise text.Continue reading -> Image Credits: Pxhere. Green Light For First-Ever WHO Strategy On Health, Environment And Climate Change 23/05/2019 Catherine Saez Faced by an annual death toll of nearly 13 million people due to environmental risks, the World Health Assembly today approved a first-ever global strategy that sets out a transformative plan for action on Health, environment and climate change.Continue reading -> Image Credits: WHO. Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year.Continue reading -> Image Credits: WHO, Vital Strategies. How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- and gene-therapies and diagnostic tests.Continue reading -> Image Credits: Dashiell Love. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Green Light For First-Ever WHO Strategy On Health, Environment And Climate Change 23/05/2019 Catherine Saez Faced by an annual death toll of nearly 13 million people due to environmental risks, the World Health Assembly today approved a first-ever global strategy that sets out a transformative plan for action on Health, environment and climate change.Continue reading -> Image Credits: WHO. Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year.Continue reading -> Image Credits: WHO, Vital Strategies. How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- and gene-therapies and diagnostic tests.Continue reading -> Image Credits: Dashiell Love. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Five Billion People Still At Risk From Industrial Trans Fat Exposure 23/05/2019 Elaine Ruth Fletcher Some 28 WHO member states, representing 31 percent of the global population, have moved to restrict or ban the use of health-harmful industrial trans fats (TFAs) in food products – but that leaves two-thirds of the world’s population still exposed to risks from TFAs that kill approximately half a million people a year.Continue reading -> Image Credits: WHO, Vital Strategies. How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- and gene-therapies and diagnostic tests.Continue reading -> Image Credits: Dashiell Love. Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- and gene-therapies and diagnostic tests.Continue reading -> Image Credits: Dashiell Love. Posts navigation Older postsNewer posts